Carson Block of Muddy Waters announced Grifols (GRFS) as a short idea for the Robin Hood contest, according to Bloomberg.Optimize Your ...

Muddy Waters CEO Carson Block picked Grifols (GRFS) as a short for the Robin Hood Foundation’s stock picking contest. However, said in an ...

As European markets face uncertainty due to U.S. trade policy and recent ECB rate cuts, the pan-European STOXX Europe 600 Index has snapped a 10-week streak of gains, although increased defense and ...

The global HIV diagnostics market, valued at US$2.96B in 2024, is forecasted to grow at a 10.3% CAGR, reaching US$3.25B by ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.

New research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...

CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future.06-March-2025 / 09:01 CET/CESTDisclosure of an inside information acc. to ...

Grifols shares lost more than 5% on the stock market on Monday. Last Friday, after the market had closed, a report was ...

European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 1.03% to 1,388.44 on the S&P Europe Select ADR Index. From continental Europe, the gainers ...

People looking to pocket some extra cash might ask, "Can I sell my kidney?" These are the parts of your body you can profit ...